Loading...

Biotechnology

Welcome to
Argutari Pharma

If you have any questions or comment you would like to make to Argutari Pharma, please click here.

Contact Us
Shape 1
Shape 2
Shape 3
Shape 4
Shape 5
Shape 6
Shape 7
Shape 8

Our Philosophy

At Argutari Pharma, the philosophy we apply to our research programs ensures that we achieve two important outcomes...

Learn More
Shape 9 Shape 10

Our Research

Argutari Pharma’s path to clinical research is clearly spelt out, and that is to leave no stone unturned...Learn More

Shape 9 Shape 10

Our Commitment

The entire team at Argutari Pharma are focussed on assuring the companies responsibilities to medical science...

Learn More
Shape 9 Shape 10
About Us
About Us

Argutari Pharma is a bio-technology specialist, that via systematic analysis, produce medically proven cures and treatments using marijuana as the primary element in our extensive research programs, ensuring the requirements of the patient are placed at the forefront by creating treatments and cures for several of the worst type of conditions and diseases known to the human race.

The entire team at Argutari Pharma are focussed solely on assuring the companies responsibilities to medical science and the ensuing benefits to patients around the world is taken very seriously.

We're dedicated to our work and engage in all elements of clinical analysis and advancement, testing and trials within a moral and accountable process, whilst seeking revolutionary, scientific and medical breakthroughs.

BG Shape 1
Shape 4
Medical Focus

What We Do and How We Do It:

Tell Me More

General Medicine

The study, development and clinical studies we perform at Argutari Pharma are assisting doctors, physicians as well as their global patients, more effectively cope with a number of medical conditions along with associated suffering.

General Medicine

Oncology

Throughout the arena of oncology, we accomplish this through exclusively incorporating our profound understanding in primary areas of biology with cutting-edge technological know-how.

Learn More

Immunology

We target remedies and therapies that will strengthen the quality of healthcare for this generation and the next. We are continuously discovering unknown areas of treatment that can significantly help the patient.

Learn More

Neuroscience

These conditions and illnesses count among them; multiple sclerosis, Parkinson’s disease as well as Alzheimer’s. We are furthermore improving research throughout numerous neurodegenerative disorders, like multiple sclerosis.

Learn More

Virology

It is believed that more than seventy million people are have contracted HCV globally. The documented occurrence of new infections is estimated at almost twenty four cases per hundred thousand people every year.

Learn More
Let's Talk

Want to get in touch?

Please find our contact details here or request a callback below:

Request a callback

Meet Our Team

Led by Passionate Experts

Meet All
Oliver Poirier

Oliver Poirier

Chairman & CEO
Alain Bergeron

Alain Bergeron

Director of Product Development
Trevor Moore

Trevor Moore

Vice President, Commercial
Brian Cameron

Brian Cameron Ph.D

Director of Formulation Sciences
Press Releases

Argutari News & Press

Argutari Pharma to Partner One of the World's Largest Privately Held Fitness Companies to Help Introduce CBD to the Fitness Industry
4 Mar, 2020
By: Argutari Pharma

Argutari Pharma to Partner One of the World's Largest Privately Held Fitness Companies to Help Introduce CBD to the Fitness Industry

Argutari Pharma, in partnership with the world-famous Gold's Gym are to introduce elite and recreational athletes alike to the health-promoting properties of CBD.

Continue Reading
Argutari Pharma Announce Cannabis Patch
24 Feb, 2020
By: Argutari Pharma

Argutari Pharma Announce Cannabis Patch

Argutari's patches that stick to the skin, even during exercise, will be available in a variety of formulas containing CBD

Continue Reading
Argutari Pharma Submit Supplemental New Drug Application to U.S. FDA for Siroliex
6 Feb, 2020
By: Argutari Pharma

Argutari Pharma Submit Supplemental New Drug Application to U.S. FDA for Siroliex

Argutari Pharma Canada's leader in the science, development, and commercialization of cannabinoid prescription medicines

Continue Reading

Investor Program

Our Investor Program is crucial to our company’s long term success and we endeavor to establish long-lasting, mutually rewarding relationships with all investors, large or small.

+1 514 907 5845

More About Our Investor Program